Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Norwegians should wear face masks more, PM says

11/30/2021 | 04:28am EST

OSLO, Nov 30 (Reuters) - Norwegians should wear face masks on crowded public transport, in shopping malls and in taxis following a record surge in coronavirus infections, Prime Minister Jonas Gahr Stoere said on Tuesday.

He stopped short of issuing mask mandates, as called for by some municipalities, urging instead an accelerated drive to give booster shots to all adults.

"Vaccination is key to our COVID-19 strategy," Stoere told parliament. "We can avoid a lockdown."

Daily infections have averaged 2,642 people in the last seven days in Norway, the highest on record, up from 2,145 in the preceding seven-day period, government figures show.

Face masks were not proposed for night clubs, concert halls or other entertainment venues, as such recommendations could hurt the economy while having limited impact on the spread of the virus, Stoere later told a news conference.

But he said the discovery earlier this month of the Omicron variant had added to uncertainty.

"We will introduce stricter measures if necessary," he said.

Norway in September ended all domestic coronavirus restrictions, but opposition parties in recent days have called on the government to act to prevent the spread of the virus and thus avoid a hard lockdown of society.

The centre-left minority government on Monday said it would seek to limit any potential spread of the Omicron variant, including by imposing longer isolation https://www.reuters.com/business/healthcare-pharmaceuticals/norway-seeks-slow-down-any-omicron-spread-government-says-2021-11-29 on those found to have been infected.

While 88% of adults in Norway have received at least two vaccine doses against COVID-19, and 71% of the overall population has been inoculated, hospitalisations and mortality are rising.

The government on Nov. 12 said it would offer booster vaccine shots https://www.reuters.com/world/europe/norway-plans-third-covid-19-vaccine-dose-all-adults-2021-11-12 to everyone aged 18 and older and give municipalities the option of using digital "corona passes", but this has not halted the rise of infection.

Norway uses vaccines made by BioNTech, Pfizer and Moderna in its national rollout, which since September has included everyone aged 12 and over. (Editing by Alex Richardson and Barbara Lewis)

ę Reuters 2021
All news about MODERNA, INC.
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
01/26Moderna Launches Mid-Stage Study of Omicron-Specific Booster Jab
01/26Moderna starts trial for Omicron-specific booster shot
01/26Moderna starts trial testing Omicron-specific booster shot
01/26MODERNA : Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster C..
01/26Moderna begins testing omicron-matched COVID shots in adults
01/26Moderna starts clinical trial of booster shot targeting omicron…
01/26Moderna Starts Clinical Trial Of Booster Shot Targeting Omicron Covid Variant - CNBC
01/26Moderna's Shares Rise After Deutsche Bank Upgrade
01/26Today on Wall Street: Need help?
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 769 M - -
Net income 2021 11 260 M - -
Net cash 2021 11 938 M - -
P/E ratio 2021 5,83x
Yield 2021 -
Capitalization 62 828 M 62 828 M -
EV / Sales 2021 2,86x
EV / Sales 2022 1,85x
Nbr of Employees 1 300
Free-Float 90,5%
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 154,96 $
Average target price 265,41 $
Spread / Average Target 71,3%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-38.99%62 828
LONZA GROUP AG-20.54%48 784
IQVIA HOLDINGS INC.-17.54%44 443
SEAGEN INC.-20.08%22 592
CELLTRION, INC.-21.21%18 165